\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ physical\\ examination\ \(0\)\
\-\ ace\\ 118\\ u\\/l\\ \\(nl\\ is\\ less\\ than\\ 67\\)\ \(0\)\
\-\ none\\ to\\ date\ \(2\)\
\-\ \\â\\€\\¢\\ ct\\:\\ edema\\ in\\ both\\ frontal\\ lobes\ \(0\)\
\-\ \\â\\€\\¢\\ mr\\:\\ diffuse\\ thickening\\ of\\ the\\ basal\\ meninges\\ with\\ intense\\ enhancement\\.\\ edema\\ at\\ the\\ base\\ of\\ both\\ frontal\\ lobes\\.\\ \\ pan\\ sinusitis\\.\ \(0\)\
\-\ leptomeningeal\\ sarcoid\ \(0\)\
\-\ \\â\\€\\¢\\ tb\\,\\ fungal\\,\\ granulomatous\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ bechets\\ disease\ \(0\)\
\-\ 44\\ year\\ old\\ \\ woman\\ who\\ presents\\ with\\ 3\\ months\\ of\\ headache\\ and\\ decreased\\ visual\\ acuity\\.\ \(1\)\
\-\ chest\\ radiographic\\ is\\ normai\\ and\\ the\\ ct\\ of\\ the\\ chest\\ revealed\\ borderline\\ adenopathy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ normai\\:\\ 0\\.09479052068781181\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.08424808341913376\ \(0\)\
\-\ pan\\:\\ 0\\.08297748532578912\ \(0\)\
\-\ bechets\\:\\ 0\\.08297748532578912\ \(0\)\
\-\ lobes\\:\\ 0\\.08098198745627874\ \(0\)\
\-\ 118\\:\\ 0\\.07988412970802805\ \(0\)\
\-\ ace\\:\\ 0\\.06432586107430412\ \(0\)\
\-\ meninges\\:\\ 0\\.06432586107430412\ \(0\)\
\-\ borderline\\:\\ 0\\.06061789885611347\ \(0\)\
\-\ acuity\\:\\ 0\\.05786592709119734\ \(0\)\
\-\ frontal\\:\\ 0\\.057726708268459305\ \(0\)\
\-\ nl\\:\\ 0\\.057524543238352384\ \(0\)\
\-\ u\\/l\\:\\ 0\\.05596344635830402\ \(0\)\
\-\ 67\\:\\ 0\\.05512515021346841\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.054600524792291716\ \(0\)\
\-\ sinusitis\\:\\ 0\\.05316470336622159\ \(0\)\
\-\ edema\\:\\ 0\\.05197684923508153\ \(0\)\
\-\ intense\\:\\ 0\\.048656548202345246\ \(0\)\
\-\ sarcoid\\:\\ 0\\.04714732930239983\ \(0\)\
\-\ 44\\:\\ 0\\.04714732930239983\ \(0\)\
\-\ both\\:\\ 0\\.04692903205776605\ \(0\)\
\-\ date\\:\\ 0\\.0461691381388974\ \(0\)\
\-\ fungal\\:\\ 0\\.04454504934951174\ \(0\)\
\-\ granulomatous\\:\\ 0\\.044345919803627475\ \(0\)\
\-\ tb\\:\\ 0\\.04424772105563529\ \(0\)\
\-\ chest\\:\\ 0\\.04397266666790363\ \(0\)\
\-\ basal\\:\\ 0\\.04188749997998251\ \(0\)\
\-\ visual\\:\\ 0\\.041654580659754775\ \(0\)\
\-\ adenopathy\\:\\ 0\\.04091272182656175\ \(0\)\
\-\ base\\:\\ 0\\.03599417508420825\ \(0\)\
\-\ radiographic\\:\\ 0\\.03487488593321219\ \(0\)\
\-\ headache\\:\\ 0\\.03155898319963224\ \(0\)\
\-\ thickening\\:\\ 0\\.03114650074939088\ \(0\)\
\-\ less\\:\\ 0\\.03111763445508261\ \(0\)\
\-\ disease\\:\\ 0\\.03003736647775708\ \(0\)\
\-\ revealed\\:\\ 0\\.02948896655769993\ \(0\)\
\-\ mr\\:\\ 0\\.029195693246735852\ \(0\)\
\-\ examination\\:\\ 0\\.028563688553489952\ \(0\)\
\-\ diffuse\\:\\ 0\\.02781728409005715\ \(0\)\
\-\ negative\\:\\ 0\\.027442152272848113\ \(0\)\
\-\ decreased\\:\\ 0\\.027319961319618922\ \(0\)\
\-\ lymphoma\\:\\ 0\\.02626020036977942\ \(0\)\
\-\ ct\\:\\ 0\\.02570545491165684\ \(0\)\
\-\ months\\:\\ 0\\.025096142953656638\ \(0\)\
\-\ enhancement\\:\\ 0\\.02462891146368856\ \(0\)\
\-\ \\:\\:\\ 0\\.02430698529012183\ \(0\)\
\-\ than\\:\\ 0\\.024075794138906172\ \(0\)\
\-\ who\\:\\ 0\\.023956649560663464\ \(0\)\
\-\ none\\:\\ 0\\.022792682869978566\ \(0\)\
\-\ physical\\:\\ 0\\.022543067414852028\ \(0\)\
\-\ 3\\:\\ 0\\.021515865878564945\ \(0\)\
\-\ woman\\:\\ 0\\.0212247628762248\ \(0\)\
\-\ presents\\:\\ 0\\.01877036876890243\ \(0\)\
\-\ at\\:\\ 0\\.012449066159479926\ \(0\)\
\-\ is\\:\\ 0\\.012092274803972595\ \(0\)\
\-\ year\\:\\ 0\\.010280701820138868\ \(0\)\
\-\ old\\:\\ 0\\.009407898890991986\ \(0\)\
\-\ \\(\\:\\ 0\\.007767330389718931\ \(0\)\
\-\ \\)\\:\\ 0\\.0076724483022936035\ \(0\)\
\-\ the\\:\\ 0\\.005946205793704336\ \(0\)\
\-\ \\,\\:\\ 0\\.0058217218390814495\ \(0\)\
\-\ of\\:\\ 0\\.005010916163354341\ \(0\)\
\-\ to\\:\\ 0\\.00459213019831168\ \(0\)\
\-\ in\\:\\ 0\\.004531153012260806\ \(0\)\
\-\ and\\:\\ 0\\.003871161413596096\ \(0\)\
\-\ with\\:\\ 0\\.0025162188406427904\ \(0\)\
\-\ \\.\\:\\ 0\\.001908577209534746\ \(0\)\
